Sweet Basil Tolerance and Weed Control with Sulfentrazone
HortTechnology · 2026-12 · 36 (6) · 1148-1150
DOI: 10.21273/horttech05940-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift HortTechnology, 2026-12. Verfasst von Thierry E. Besançon und 1 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Sweet basil ( Ocimum basilicum L.) production is limited by weed interference and a lack of effective preemergence herbicide options. Field trials conducted in 2021 in Bridgeton, NJ, USA, evaluated crop tolerance and weed control efficacy of sulfentrazone applied alone or mixed with napropamide in three basil cultivars. Sulfentrazone applied preemergence at seeding (PREMEA) provided ≥91% control of common lambsquarters and hairy galinsoga and complete control of clammy goosefoot, outperforming napropamide alone. Delaying sulfentrazone application until after germination but before crop emergence substantially increased crop injury, reduced stand density, and decreased yield. PREMEA applications generally maintained yields comparable to the weed-free control, although cultivar sensitivity differed, with ‘Genovese’ exhibiting greater stunting. Results indicate that sulfentrazone applied PREMEA, alone or mixed with napropamide, may provide an effective residual weed management option in basil production systems.
Zitieren
APA
Besançon, T. E., & Sosnoskie, L. M. (2026). Sweet Basil Tolerance and Weed Control with Sulfentrazone. HortTechnology, 36(6), 1148-1150. https://doi.org/10.21273/horttech05940-26
Vancouver
Besançon TE, Sosnoskie LM. Sweet Basil Tolerance and Weed Control with Sulfentrazone. HortTechnology. 2026;36(6):1148-1150. doi:10.21273/horttech05940-26
BibTeX
@article{Besanon2026,
author = {Besançon, Thierry E. and Sosnoskie, Lynn M.},
title = {Sweet Basil Tolerance and Weed Control with Sulfentrazone},
journal = {HortTechnology},
year = {2026},
volume = {36},
number = {6},
pages = {1148--1150},
doi = {10.21273/horttech05940-26}
}
EUVIMED